Key Financial Data Of Group

Astellas Pharma Inc. - Filing #7586679

Concept 2022-07-01 to
2022-09-30
As at
2022-09-30
2022-04-01 to
2022-09-30
2021-04-01 to
2022-03-31
As at
2022-03-31
As at
2021-09-30
2021-07-01 to
2021-09-30
2021-04-01 to
2021-09-30
Key financial data of group
Business results of group
Cash and cash equivalents
361,073,000,000 JPY
315,986,000,000 JPY
318,295,000,000 JPY
Revenue
380,394,000,000 JPY
762,185,000,000 JPY
1,296,163,000,000 JPY
325,523,000,000 JPY
651,666,000,000 JPY
Profit (loss) before tax
120,480,000,000 JPY
156,886,000,000 JPY
89,085,000,000 JPY
Profit (loss), attributable to owners of parent
71,623,000,000 JPY
96,434,000,000 JPY
124,086,000,000 JPY
40,922,000,000 JPY
71,609,000,000 JPY
Comprehensive income, attributable to owners of parent
243,707,000,000 JPY
208,117,000,000 JPY
70,077,000,000 JPY
Equity attributable to owners of parent
1,649,518,000,000 JPY
1,460,308,000,000 JPY
1,417,622,000,000 JPY
Total assets
2,583,661,000,000 JPY
2,332,395,000,000 JPY
2,261,508,000,000 JPY
Basic earnings (loss) per share
39.30
52.87
67.08
22.09
38.65
Diluted earnings (loss) per share
52.85
67.05
38.63
Ratio of owners' equity to gross assets
0.638 xbrli:pure
0.626 xbrli:pure
0.627 xbrli:pure
Cash flows from (used in) operating activities
139,857,000,000 JPY
257,444,000,000 JPY
139,385,000,000 JPY
Cash flows from (used in) investing activities
-34,660,000,000 JPY
-62,413,000,000 JPY
-55,744,000,000 JPY
Cash flows from (used in) financing activities
-81,431,000,000 JPY
-216,298,000,000 JPY
-89,936,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.